The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.40
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.20 (14.286%)
Open: 1.50
High: 1.50
Low: 1.50
Prev. Close: 1.50
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Jan 2018 15:52

RNS Number : 1812C
Physiomics PLC
17 January 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

PHYSIOMICS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Jason Cropper

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

15 January 2018

6. Date on which issuer notified (DD/MM/YYYY):

15 January 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.4%

58,785,394

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

2,000,000

3.4%

SUBTOTAL 8. A

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Preston

Date of completion

15 January 2018

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEDLFFVFFEBBF
Date   Source Headline
5th Aug 20207:00 amRNSIssue of Equity and Director Dealing
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSPhysiomics awarded contract by Astellas Pharma Inc
22nd Jul 202011:45 amRNSShare Price Movement
17th Jul 20209:00 amRNSPrice Monitoring Extension
6th Jul 202010:00 amRNSDirector dealing
30th Jun 20202:30 pmRNSContract award and update
22nd Jun 20207:00 amRNSConference presentation
10th Jun 20201:00 pmRNSHolding(s) in Company
27th May 20207:00 amRNSFundraise
15th May 20201:00 pmRNSHolding(s) in Company
28th Apr 20202:50 pmRNSConference attendance and presentation
16th Apr 20207:00 amRNSConfirmation of Twitter account
9th Apr 202012:28 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSAwarded further Bicycle Therapeutics contract
19th Mar 20207:00 amRNSCOVID-19 update
10th Mar 20207:00 amRNSNIHR i4i award
5th Mar 20207:00 amRNSPhysiomics awarded further contract by Merck
3rd Mar 20207:00 amRNSAwarded two further contracts by Bicycle
27th Dec 20193:45 pmRNSHolding(s) in Company
23rd Dec 20197:00 amRNSContract award
20th Dec 201910:30 amRNSMerck Contracts
19th Nov 201912:52 pmRNSResult of AGM
21st Oct 20197:00 amRNSDispatch of Annual Report and Notice of AGM
30th Sep 20197:00 amRNSFinal Results for the Year Ended 30 June 2019
5th Aug 20197:00 amRNSDirector Dealing
30th Jul 20197:00 amRNSTrading Update
22nd Jul 20199:03 amRNSHolding(s) in Company
8th Jul 20197:00 amRNSAgreement with Bicycle and Cancer Research UK
2nd Jul 20191:30 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSContract Award
31st May 20197:00 amRNSChange of Adviser
14th May 20197:00 amRNSInnovate UK Award Project
3rd May 201912:00 pmRNSPhysiomics participates at NIHR event
30th Apr 20192:00 pmRNSConference attendance and presentation
27th Mar 20191:00 pmRNSIssue of Options
26th Mar 20191:00 pmRNSAIM Rule 26 Website Change
20th Mar 20197:00 amRNSConference Attendance and Presentation
21st Feb 20197:00 amRNSInterim Results
7th Jan 20197:00 amRNSConference Attendance
3rd Jan 20197:00 amRNSStrategic Collaboration
17th Dec 20187:00 amRNSRenewal of Agreement with Merck
20th Nov 201812:56 pmRNSResult of AGM
15th Oct 20181:00 pmRNSDispatch of Annual Report and Shareholder Circular
8th Oct 20187:00 amRNSFinal Results for the Year Ended 30 June 2018
9th Aug 20187:00 amRNSContract award
2nd Jul 20181:57 pmRNSPhysiomics Expands Technical Team
21st Jun 20187:00 amRNSTrading Update
11th Jun 20184:05 pmRNSUpdated Website
23rd May 20187:00 amRNSPlacing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.